Allergic rhinitis in children — a consensus document of the Association of Pediatric Allergists and Immunologists of Russia
Authors:
- Yu. S. SmolkinYSYu. S. Smolkin
- S. S. MasalskiySMS. S. Masalskiy
- L. Yu. BarychevaLBL. Yu. Barycheva
- N. A. BelykhNBN. A. Belykh
- K. A. BocharovaKBK. A. Bocharova
- Yu. N. EmelinaYEYu. N. Emelina
- A. V. KamaevAKA. V. Kamaev
- E. M. KamaltynovaEKE. M. Kamaltynova
- E. P. KarpovaEKE. P. Karpova
- I. A. LarkovaILI. A. Larkova
- T. S. LepeshkovaTLT. S. Lepeshkova
Open Access
- 30 July 2026
- journal article
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 1,p. 6-184
Abstract
Background. Allergic rhinitis (AR) is the most prevalent allergic disease globally, particularly within the pediatric population. Its high prevalence and substantial impact on quality of life render it a pressing clinical concern. Notable challenges persist in early diagnosis, comprehension of pathogenetic mechanisms, and optimization of therapeutic strategies, especially in young children. Objective. To present a contemporary review and consensus recommendations from the Association of Pediatric Allergists and Immunologists of Russia (APAIR) on the management of pediatric AR, encompassing pathogenetic mechanisms, risk factors, clinical presentation, diagnostic approaches, and therapeutic modalities. Materials and Methods. This work synthesizes current national and international research, including data from meta-analyses and clinical guidelines, alongside original expert contributions from APAIR members. Results. Experts conceptualize AR as a mixed immune-inflammatory disorder involving the classical IgE-dependent pathway (Type I), cellular responses (Type IV), and epithelial dysfunction (Type V). The significance of risk factors, including genetics, microbiome composition, pollutant exposure, and allergen contact, is underscored. Data on the substantial prevalence of AR are presented, highlighting its underdiagnosis in young children and patients with comorbid conditions such as atopic dermatitis and food allergy. A refined, more clinically applicable definition of AR is proposed. Algorithms for stepwise pharmacotherapy are thoroughly detailed, including the evidence-based use of antihistamines as initial therapy for young children and patients with mild AR, intranasal corticosteroids as the cornerstone of treatment, and fixed intranasal combinations for both baseline and on-demand therapy. A personalized approach based on age (0–18 years) and clinical phenotype is emphasized. APAIR experts underscore the role of allergen-specific immunotherapy (AIT) as the only disease-modifying intervention, in contrast to pharmacotherapy, which primarily provides symptomatic control. Conclusion. Timely diagnosis and appropriate, stepwise therapy for AR in children facilitate symptom control and significantly improve patients’ quality of life. Furthermore, the incorporation of AIT can prevent disease progression, including the development of bronchial asthma. This consensus document aims to assist clinicians in making evidence-based clinical decisions.Keywords
This publication has 510 references indexed in Scilit:
- Association Between Habitual Snoring and Cognitive Performance Among a Large Sample of Preadolescent ChildrenJAMA Otolaryngology–Head & Neck Surgery, 2021
- Intranasal corticosteroids for non-allergic rhinitisCochrane Database of Systematic Reviews, 2019
- Saline irrigation for allergic rhinitisCochrane Database of Systematic Reviews, 2018
- Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic RhinoconjunctivitisJAMA Internal Medicine, 2015
- Total serum immunoglobulin E as a marker for missed antigens on in vitro allergy screeningInternational Forum of Allergy & Rhinology, 2013
- Antihistamines and/or decongestants for otitis media with effusion (OME) in childrenCochrane Database of Systematic Reviews, 2011
- Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in childrenCochrane Database of Systematic Reviews, 2011
- Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitisCochrane Database of Systematic Reviews, 2003
- Fluticasone Nasal Spray and the Combination of Loratadine and Montelukast in Seasonal Allergic RhinitisJAMA Otolaryngology–Head & Neck Surgery, 2003
- Serum Level of Placental Growth Hormone Is Raised in Pregnancy RhinitisJAMA Otolaryngology–Head & Neck Surgery, 1998